FRA:FRE • DE0005785604
The current stock price of FRE.DE is 48.44 EUR. Today FRE.DE is up by 2.76%. In the past month the price decreased by -5.76%. In the past year, price increased by 18.86%.
ChartMill assigns a technical rating of 1 / 10 to FRE.DE. When comparing the yearly performance of all stocks, FRE.DE turns out to be only a medium performer in the overall market: it outperformed 68.95% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to FRE.DE. FRE.DE has an average financial health and profitability rating.
On February 25, 2026 FRE.DE reported an EPS of 0.63 and a revenue of 5.96B. The company missed EPS expectations (-28.85% surprise) and missed revenue expectations (-1.28% surprise).
23 analysts have analysed FRE.DE and the average price target is 56.38 EUR. This implies a price increase of 16.38% is expected in the next year compared to the current price of 48.44.
For the next year, analysts expect an EPS growth of 16.18% and a revenue growth 4.95% for FRE.DE
Over the last trailing twelve months FRE.DE reported a non-GAAP Earnings per Share(EPS) of 3.2. The EPS increased by 6.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.11% | ||
| ROA | 2.69% | ||
| ROE | 6.14% | ||
| Debt/Equity | 0.61 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1FME | FRESENIUS MEDICAL CARE AG | 9.65 | 23.491B | ||
| FME | FRESENIUS MEDICAL CARE AG | 9.83 | 23.332B | ||
| HI | HEALTH ITALIA SPA | N/A | 56.81M | ||
| EUK | EUKEDOS SPA | N/A | 15.236M | ||
| V3V | FAMICORD AG | N/A |
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen and currently employs 177,356 full-time employees. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.
IPO: 1986-12-18
FRESENIUS SE & CO KGAA
Else-Kroener-Str. 1
BAD HOMBURG HESSEN DE
Employees: 176486
Phone: 4961726080
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen and currently employs 177,356 full-time employees. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.
The current stock price of FRE.DE is 48.44 EUR. The price increased by 2.76% in the last trading session.
FRESENIUS SE & CO KGAA (FRE.DE) has a dividend yield of 2.26%. The yearly dividend amount is currently 0.
FRE.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
23 analysts have analysed FRE.DE and the average price target is 56.38 EUR. This implies a price increase of 16.38% is expected in the next year compared to the current price of 48.44.
FRESENIUS SE & CO KGAA (FRE.DE) operates in the Health Care sector and the Health Care Providers & Services industry.